APA ציטוט

Ozgonul, C., Dedania, V. S., & Besirli, C. G. (2018). Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion. J Ocul Pharmacol Ther.

Citação norma Chicago

Ozgonul, Cem, Vaidehi S. Dedania, and Cagri G. Besirli. "Aflibercept Versus Bevacizumab And/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion." J Ocul Pharmacol Ther 2018.

ציטוט MLA

Ozgonul, Cem, Vaidehi S. Dedania, and Cagri G. Besirli. "Aflibercept Versus Bevacizumab And/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion." J Ocul Pharmacol Ther 2018.